Prestige Consumer Healthcare
253 hedge funds and large institutions have $2.08B invested in Prestige Consumer Healthcare in 2020 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 96 increasing their positions, 92 reducing their positions, and 33 closing their positions.
373% more call options, than puts
Call options by funds: $1.29M | Put options by funds: $273K
12% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 33
1.98% more ownership
Funds ownership: 108.56% → 110.53% (+2%)
4% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 92
4% more capital invested
Capital invested by funds: $2B → $2.08B (+$76.2M)
1% more funds holding
Funds holding: 251 → 253 (+2)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$28.5M |
| 2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$16.6M |
| 3 |
Renaissance Technologies
New York
|
+$13.9M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$9.88M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$9.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$26.5M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$13.7M |
| 3 |
Truist Financial
Charlotte,
North Carolina
|
-$13.4M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$12.3M |
| 5 |
BlackRock
New York
|
-$9.19M |
PBH Hedge Fund Activity: Q2 2020 in Review
253 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2020, worth a combined $2.08B — up 3.8% from $2B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new PBH positions and 33 closed out — a net gain of 4 holders — while 96 added to existing stakes and 92 trimmed.
The largest buyer was Invesco, adding an estimated $28.5M. The largest seller was JP Morgan Chase, cutting an estimated $26.5M.
- 253 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2020, up from 251 in Q1 2020.
- Funds reported $2.08B of Prestige Consumer Healthcare stock for Q2 2020, up 3.8% quarter-over-quarter.
- 37 funds opened new Prestige Consumer Healthcare positions in Q2 2020 and 33 closed out, a net change of +4 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2020 was Invesco, an estimated $28.5M added.
- The largest Prestige Consumer Healthcare seller in Q2 2020 was JP Morgan Chase, an estimated $26.5M sold.
Based on aggregated 13F filings for Q2 2020.